A DENTAL company has received a coveted accolade.

Silsden-based EthOss Regeneration Ltd has been presented with a Queen’s Award for Enterprise, in the international trade category.

The company is among 205 organisations nationally to be recognised in this year’s awards, which celebrate outstanding achievement by UK businesses.

Recipients are able to use the revered Queen’s Award logo for five years.

EthOss managing director, Dr Paul Harrison, said: “We’re incredibly proud to have been recognised with the prestigious Queen’s Award in international trade.

“Exports now account for 58 per cent of our total turnover.

“We recently signed partnerships with distributors in France, Turkey, Chile, Kuwait, Latvia and Moldova, with EthOss now being sold in more than 45 countries worldwide.

“The hard work of our team has seen us continue to grow year-on-year and we’re extremely honoured that this has been celebrated with such a renowned and well-respected award.”

Despite the pandemic, the company has experienced continued growth. Turnover and total exports increased by 22 per cent in 2019-20.

The firm – based at Ryefield Court – was set-up in 2013 by Dr Harrison, a biomaterial product development specialist, and world-renowned dental surgeon Dr Peter Fairbairn.

Together they created the company’s flagship product, EthOss, a synthetic biomaterial used during dental implant surgery.

It is designed to encourage new bone to grow and support the implant.

Previously the procedure had been carried out using a material containing animal product – usually bone harvested from cows, pigs and horses.

EthOss works with the body to create the ideal conditions for bone regrowth, without using animal or human content.

It is made from a mixture of beta Tricalcium Phosphate and Calcium Sulphate.

The Calcium Sulphate acts as a built-in barrier against soft tissue ingress, removing the need for an additional collagen membrane. The feature is popular with dentists who often find collagen membranes difficult to handle and an expensive addition to a procedure.

“Our aim is to grow a more ethical approach to dental implantology worldwide,” added Dr Harrison.